Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 9,537,428,800
  • Market Capitalization, $K 9,537,429
  • Shares Outstanding, K 68,200
  • 60-Month Beta 1.15
Trade IBB with:
  • Price/Earnings ttm 21.90
  • Annual Dividend & Yield 0.30 (0.22%)
  • Most Recent Dividend 0.063 on 09/23/20
  • Management Fee 0.46%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.25 +6.33%
on 09/24/20
144.82 -5.10%
on 10/14/20
+1.11 (+0.81%)
since 09/18/20
3-Month
126.00 +9.07%
on 09/04/20
146.53 -6.21%
on 07/20/20
-6.53 (-4.54%)
since 07/17/20
52-Week
92.15 +49.14%
on 03/16/20
146.53 -6.21%
on 07/20/20
+35.16 (+34.38%)
since 10/18/19

Most Recent Stories

More News
Biotech ETFs to Shine on Coronavirus Antibodies Progress

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
PBE : 60.94 (-0.84%)
ARKG : 73.27 (-0.56%)
5 ETFs That Make Attractive Investment Choices in Q4

Here we discuss ETFs that can be a good addition for enhanced portfolio returns in the fourth quarter of 2020.

IBB : 137.43 (-1.63%)
ICLN : 20.73 (-0.77%)
IBUY : 96.52 (-0.64%)
VGT : 320.80 (-1.53%)
ESPO : 61.11 (-1.10%)
Biotech ETFs to Gain on Trump's COVID-19 Treatment Protocol

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
PBE : 60.94 (-0.84%)
ARKG : 73.27 (-0.56%)
Top-Performing Biotech ETFs Amid the Coronavirus Crisis

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
ARKG : 73.27 (-0.56%)
Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
FBT : 157.99 (-1.64%)
ARKG : 73.27 (-0.56%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 60.94 (-0.84%)
REGN : 583.14 (-2.77%)
AMGN : 230.71 (-2.13%)
IBB : 137.43 (-1.63%)
OPK : 4.59 (+6.87%)
XBI : 118.29 (-1.93%)
ETFs to Gain as AstraZeneca Resumes Coronavirus Vaccine Trial

AstraZeneca's resumption of the late-stage trials can revive investors optimism surrounding the coronavirus vaccine development.

IBB : 137.43 (-1.63%)
CNCR : 28.74 (-2.77%)
XBI : 118.29 (-1.93%)
PPH : 62.06 (-1.52%)
BBH : 160.30 (-1.75%)
How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
FBT : 157.99 (-1.64%)
ARKG : 73.27 (-0.56%)
ETF Areas to Consider This Cursed September Amid Coronavirus

Let's look at some ETF areas one can consider investing in for a smooth sail amid the turbulences September can usher in.

VIS : 151.87 (-1.20%)
IBB : 137.43 (-1.63%)
VCR : 243.60 (-1.27%)
XBI : 118.29 (-1.93%)
XLY : 150.97 (-1.23%)
VIG : 132.06 (-1.58%)
DOG : 43.00 (+1.32%)
VYM : 82.86 (-1.42%)
KRE : 39.15 (-0.66%)
DXD : 15.10 (+2.79%)
Will Novavax ETFs Gain on Coronavirus Vaccine Progress?

Investors are closely tracking the progress in the coronavirus vaccine development amid the coronavirus outbreak.

IBB : 137.43 (-1.63%)
XBI : 118.29 (-1.93%)
BBH : 160.30 (-1.75%)
PTH : 144.26 (-1.13%)
DWAS : 64.39 (-0.91%)
GERM : 29.08 (-2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 142.29
1st Resistance Point 139.86
Last Price 137.43
1st Support Level 135.88
2nd Support Level 134.33

See More

52-Week High 146.53
Last Price 137.43
Fibonacci 61.8% 125.76
Fibonacci 50% 119.34
Fibonacci 38.2% 112.92
52-Week Low 92.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar